Glycemic control in mice with targeted disruption of the glucagon receptor gene.

The action of glucagon in the liver is mediated by G-coupled receptors. To examine the role of glucagon in glucose homeostasis, we have generated mice in which the glucagon receptor was inactivated (GR(-/-) mice). Blood glucose levels were somewhat reduced in GR(-/-) mice relative to wild type, in both the fed and fasted state. Plasma insulin levels were not significantly affected. There was no significant effect on fasting plasma cholesterol or triglyceride levels associated with deletion of the glucagon receptor. Glucose tolerance, as assessed by an oral glucose tolerance test, improved. Plasma glucagon levels were strikingly elevated in both fed and fasted animals. Despite a total absence of glucagon receptors, these animals maintained near-normal glycemia and normal lipidemia, in the presence of circulating glucagon concentrations that were elevated by two orders of magnitude.

[1]  Carolyn B Levy,et al.  Effects of skyrin, a receptor-selective glucagon antagonist, in rat and human hepatocytes. , 2000, Diabetes.

[2]  B. Koller,et al.  A new embryonic stem cell line from DBA/1lacJ mice allows genetic modification in a murine model of human inflammation. , 1995, Experimental cell research.

[3]  F J Grant,et al.  Expression cloning and signaling properties of the rat glucagon receptor. , 1993, Science.

[4]  R. B. Merrifield,et al.  Biological activities of des-His1[Glu9]glucagon amide, a glucagon antagonist , 1989, Peptides.

[5]  Mario R. Capecchi,et al.  Disruption of the proto-oncogene int-2 in mouse embryo-derived stem cells: a general strategy for targeting mutations to non-selectable genes , 1988, Nature.

[6]  A. Read Comparative evidence supports the Hamilton and Zuk hypothesis on parasites and sexual selection , 1987, Nature.

[7]  A. Baron,et al.  Role of Hyperglucagonemia in Maintenance of Increased Rates of Hepatic Glucose Output in Type II Diabetics , 1987, Diabetes.

[8]  A. Golay,et al.  Documentation of hyperglucagonemia throughout the day in nonobese and obese patients with noninsulin-dependent diabetes mellitus. , 1987, The Journal of clinical endocrinology and metabolism.

[9]  V. Hruby,et al.  Activation of two signal-transduction systems in hepatocytes by glucagon , 1986, Nature.

[10]  F. Sistare,et al.  Sensitivity of the response of cytosolic calcium in Quin-2-loaded rat hepatocytes to glucagon, adenine nucleosides, and adenine nucleotides. , 1985, The Journal of biological chemistry.

[11]  V. Hruby,et al.  Hyperglycemia of diabetic rats decreased by a glucagon receptor antagonist. , 1982, Science.

[12]  G WhittakerP,et al.  共やくエクイン・エストロゲン(Premarin)服用閉経婦人の血清エクイリン,エストロン,エストラジオール値 , 1980 .

[13]  S. Elek,et al.  Further Studies Concerning Glucagon-lnduced Hypocholesterolemia 1 , 1975, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[14]  L. Orci,et al.  Glucagon: role in the hyperglycemia of diabetes mellitus. , 1975, Science.

[15]  L. Orci,et al.  THE ESSENTIAL ROLE OF GLUCAGON IN THE PATHOGENESIS OF DIABETES MELLITUS , 1975, The Lancet.

[16]  R. Stephens Letter: Splenectomy and lymphomas. , 1975, Lancet.

[17]  S. Elek,et al.  Effect of glucagon on blood-cholesterol levels in rats. , 1971, Lancet.

[18]  L. Birnbaumer,et al.  The glucagon-sensitive adenyl cyclase system in plasma membranes of rat liver. 3. Binding of glucagon: method of assay and specificity. , 1971, The Journal of biological chemistry.

[19]  L. Birnbaumer,et al.  The glucagon-sensitive adenyl cyclase system in plasma membranes of rat liver. IV. Effects of guanylnucleotides on binding of 125I-glucagon. , 1971, The Journal of biological chemistry.